Read more about the article Clinical Research Update – February 2025
Clinical Research Updates Latest Newsletter February 2025

Clinical Research Update – February 2025

Clinical Research Updates provides key insights into the latest developments, trends, and breakthroughs shaping the clinical research landscape. Stay informed with concise summaries of regulatory updates, industry collaborations, and advancements…

Continue ReadingClinical Research Update – February 2025
Read more about the article FDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria
FDA Issues New Draft Guidances On Cancer Clinical Trial Eligibility Criteria

FDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria

The FDA recently unveiled the draft guidance for the industry titled, “Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.” This draft guidance serves as a framework for maintaining the highest standards of data integrity in clinical and bioanalytical domains, crucial for supporting investigational new drug applications, new drug applications, and abbreviated new drug applications.

Continue ReadingFDA’s New Draft Guidances on Cancer Clinical Trials Eligibility Criteria
Read more about the article Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies
Ensuring Data Integrity: FDA's Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

The FDA recently unveiled the draft guidance for the industry titled, “Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.” This draft guidance serves as a framework for maintaining the highest standards of data integrity in clinical and bioanalytical domains, crucial for supporting investigational new drug applications, new drug applications, and abbreviated new drug applications.

Continue ReadingEnsuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies